MYCO:CC News and Press, MYDECINE INNOVATIONS GROUP INC. From 05/18/22

Mydecine Overnight Marketed Public Offering of Units Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 18, 2022 /CNW/ - Mydecine Innovations Group Inc. (" Mydecine " or the ...

IIROC Trading Halt - MYCO Canada NewsWire TORONTO , May 18, 2022 /CNW/ - The following issues have been halted by IIROC: Company: MYDECINE INNOVATIONS GROUP INC. NEO Exchange Symbol : MYCO All Issues: Yes Reason: Pending News Halt ...

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financi...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons , the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman says LSD and MDMA helped him alleviate symptoms rel...

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT Canada NewsWire DENVER , May 2, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce...

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT Canada NewsWire DENVER , April 27, 2022 /CNW/ - Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that in connection wi...

Mydecine Announces Reverse Stock-Split Canada NewsWire DENVER , April 13, 2022 /CNW/ - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (" Mydecine " or the " Company "), today announces its Board of Directors has voted in favo...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety med...

In 2021, Mydecine made significant progress in creating and commercializing new treatments for mental health and addiction disorders It also made a noteworthy shift in focus to reducing expenses and increasing efficiencies for continued clinical trials and the expansion of its IP portfo...

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. A recent article discusses the company’s efforts to lead the charge toward developing novel psychedelic an...